Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate sodium in Graves' orbitopathy
2008-002123-93Phase 2Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of mycophenolate sodium in Graves' ophthalmopathy (TED) and Graves' disease (2 arms), sponsored by Johannes Gutenberg University Mainz. Primary endpoints: Response rate at week 12 and Safety of combination treatment. Started Apr 2009; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
Graves' ophthalmopathy (TED)Graves' disease
Beyond the preview
Go deeper on 2008-002123-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002123-93.